151 related articles for article (PubMed ID: 16009516)
21. Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry.
Fix I; Steffens KJ
Drug Dev Ind Pharm; 2004 May; 30(5):513-23. PubMed ID: 15244087
[TBL] [Abstract][Full Text] [Related]
22. Compression behaviour and tablet-forming ability of spray-dried amorphous composite particles.
Berggren J; Frenning G; Alderborn G
Eur J Pharm Sci; 2004 Jun; 22(2-3):191-200. PubMed ID: 15158904
[TBL] [Abstract][Full Text] [Related]
23. The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation.
Newell HE; Buckton G; Butler DA; Thielmann F; Williams DR
Int J Pharm; 2001 Apr; 217(1-2):45-56. PubMed ID: 11292541
[TBL] [Abstract][Full Text] [Related]
24. Quantifying the rates of relaxation of binary mixtures of amorphous pharmaceuticals with isothermal calorimetry.
Alem N; Beezer AE; Gaisford S
Int J Pharm; 2010 Oct; 399(1-2):12-8. PubMed ID: 20655372
[TBL] [Abstract][Full Text] [Related]
25. Elastic modulus measurements from individual lactose particles using atomic force microscopy.
Perkins M; Ebbens SJ; Hayes S; Roberts CJ; Madden CE; Luk SY; Patel N
Int J Pharm; 2007 Mar; 332(1-2):168-75. PubMed ID: 17074456
[TBL] [Abstract][Full Text] [Related]
26. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
[TBL] [Abstract][Full Text] [Related]
27. Quantification of surface amorphous content using dispersive surface energy: the concept of effective amorphous surface area.
Brum J; Burnett D
AAPS PharmSciTech; 2011 Sep; 12(3):887-92. PubMed ID: 21725707
[TBL] [Abstract][Full Text] [Related]
28. On the physical transformations of processed pharmaceutical solids.
Price R; Young PM
Micron; 2005; 36(6):519-24. PubMed ID: 15993096
[TBL] [Abstract][Full Text] [Related]
29. The use of organic vapor sorption to determine low levels of amorphous content in processed pharmaceutical powders.
Young PM; Chiou H; Tee T; Traini D; Chan HK; Thielmann F; Burnett D
Drug Dev Ind Pharm; 2007 Jan; 33(1):91-7. PubMed ID: 17192255
[TBL] [Abstract][Full Text] [Related]
30. An X-ray diffraction analysis of crystallised whey and whey-permeate powders.
Nijdam J; Ibach A; Eichhorn K; Kind M
Carbohydr Res; 2007 Nov; 342(16):2354-64. PubMed ID: 17719020
[TBL] [Abstract][Full Text] [Related]
31. Qualitative proof of liquid dispersion and penetration-involved granule formation in a high shear mixer.
van den Dries K; Vromans H
Eur J Pharm Biopharm; 2004 Nov; 58(3):551-9. PubMed ID: 15451529
[TBL] [Abstract][Full Text] [Related]
32. Density mapping and chemical component calibration development of four-component compacts via terahertz pulsed imaging.
Palermo R; Cogdill RP; Short SM; Drennen JK; Taday PF
J Pharm Biomed Anal; 2008 Jan; 46(1):36-44. PubMed ID: 18053671
[TBL] [Abstract][Full Text] [Related]
33. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
34. The use of inverse gas chromatography and gravimetric vapour sorption to study transitions in amorphous lactose.
Ambarkhane AV; Pincott K; Buckton G
Int J Pharm; 2005 Apr; 294(1-2):129-35. PubMed ID: 15814237
[TBL] [Abstract][Full Text] [Related]
35. The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles.
Mahlin D; Berggren J; Gelius U; Engström S; Alderborn G
Int J Pharm; 2006 Sep; 321(1-2):78-85. PubMed ID: 16822629
[TBL] [Abstract][Full Text] [Related]
36. Crystallization of bulk samples of partially amorphous spray-dried lactose.
Darcy P; Buckton G
Pharm Dev Technol; 1998 Nov; 3(4):503-7. PubMed ID: 9834953
[TBL] [Abstract][Full Text] [Related]
37. Investigation into the subambient behavior of aqueous mannitol solutions using temperature-controlled Raman microscopy.
Beattie JR; Barrett LJ; Malone JF; McGarvey JJ; Nieuwenhuyzen M; Kett VL
Eur J Pharm Biopharm; 2007 Sep; 67(2):569-78. PubMed ID: 17481870
[TBL] [Abstract][Full Text] [Related]
38. HyperDSC studies of amorphous polyvinylpyrrolidone in a model wet granulation system.
Buckton G; Adeniyi AA; Saunders M; Ambarkhane A
Int J Pharm; 2006 Apr; 312(1-2):61-5. PubMed ID: 16500057
[TBL] [Abstract][Full Text] [Related]
39. An investigation of calibration methods for solution calorimetry.
Yff BT; Royall PG; Brown MB; Martin GP
Int J Pharm; 2004 Jan; 269(2):361-72. PubMed ID: 14706248
[TBL] [Abstract][Full Text] [Related]
40. Considerations on the quantitative analysis of apparent amorphicity of milled lactose by Raman spectroscopy.
Pazesh S; Lazorova L; Berggren J; Alderborn G; Gråsjö J
Int J Pharm; 2016 Sep; 511(1):488-504. PubMed ID: 27397869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
